ETERNA THERAPEUTICS INC (ERNA)
US1140822099 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.93M | -21.67M | -24.58M | -122.31M | -4.42M | |||
| Depreciation Amortization | 144.00K | 84.00K | 160.00K | 120.00K | 1.74M | |||
| Change In Working Capital | -195.00K | -2.12M | 3.71M | -2.35M | -1.08M | |||
| Interest Paid | 56.00K | 20.00K | 30.00K | 230.00K | 100.00K | |||
| Taxes Paid | 6.00K | 4.00K | 20.00K | 0.00 | 30.00K | |||
| Other non cash items | 28.03M | 3.29M | -270.00K | 101.05M | -130.00K | |||
| OPERATING CASH FLOW | -16.95M | -20.41M | -20.98M | -23.49M | -3.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -388.00K | -19.00K | -300.00K | -150.00K | -270.00K | |||
| Other Investing Activity | 4.00K | 0.00 | 250.00K | -22.59M | 1.23M | |||
| INVESTING CASH FLOW | -384.00K | -19.00K | -50.00K | -22.74M | 960.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 9.19M | 16.50M | 0.00 | -940.00K | 360.00K | |||
| Stock Issued/Repurchased | N/A | 320.00K | 19.71M | 62.54M | N/A | |||
| Dividend Paid | N/A | -16.00K | -20.00K | -10.00K | -20.00K | |||
| Other Financing Activity | 3.78M | -251.00K | -120.00K | N/A | -50.00K | |||
| FINANCING CASH FLOW | 12.96M | 16.56M | 19.58M | 61.59M | 290.00K | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 10.00K | |||
| CHANGE IN CASH | -4.38M | -3.87M | -1.45M | 15.36M | -2.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.95M | -20.41M | -20.98M | -23.49M | -3.89M | |||
| Capital Expenditure | -388.00K | -19.00K | -300.00K | -150.00K | -270.00K | |||
| FREE CASH FLOW | -17.34M | -20.43M | -21.28M | -23.64M | -4.16M | |||
All data in USD